David A. Siegel Codexis, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Codexis, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 403,700 shares of CDXS stock, worth $1.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
403,700
Previous 485,100
16.78%
Holding current value
$1.72 Million
Previous $1.49 Million
28.85%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding CDXS
# of Institutions
144Shares Held
60.6MCall Options Held
68.5KPut Options Held
20.1K-
Opaleye Management Inc. Boston, MA8.84MShares$37.7 Million8.29% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$34.5 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$28.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$19 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$12.8 Million1.53% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $279M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...